Patient Walks Again After Treatment of Severe, Refractory Dermatomyositis
Trials evaluate safety and efficacy of new treatments
Related Articles
EoE Transition Clinic Drives Continuity of Care
Special clinic helps transition patients with eosinophilic esophagitis (EoE) from pediatric to adult care.
Researchers Find Clues to Combatting Viral-Induced Cancers
Cleveland Clinic research team uncovers mechanism that transforms herpesvirus KSHV into cancer, and human enzymes that can shrink these tumors
Infective Endocarditis Due to Opioid Addiction: Two Diseases, Highly Divergent Outcomes
Successful surgery for infective endocarditis is not enough to ensure good long-term outcomes in patients with opioid use disorder, study makes clear New and different…
One Robot for Both Kidney Transplant Donor and Recipient
Surgeons choreograph nearly simultaneous procedures, sharing one robot between two patients
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood
Early communication between oncologists and ophthalmologist warranted
Case Study: EBV-Associated Primary CNS Lymphoma in a Patient on Long-Term Mycophenolate Mofetil
First reported case in a patient with diffuse cutaneous systemic sclerosis
Considerations When Evaluating Pulmonary Cysts
A Cleveland Clinic pulmonologist highlights several factors to be aware of when treating patients
Cardiac MR-Enriched Phenomapping Shows Potential to Improve Therapeutic Selection in ICM
Cardiac MR-based phenomapping represents a promising new approach to patient selection for procedural intervention for ischemic cardiomyopathy Cardiac MR-based phenomapping may be a key to…
Lung Cancer Study Links Preoperative Factors With Spread Through Air Spaces
A study has identified preop characteristics predictive of spread through air spaces (STAS) in lung cancer, promising guidance for surgical decisions.
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism
A surprising outcome has emerged from the TRAVERSE study of testosterone replacement therapy in men with hypogonadism: an increased risk of fractures relative to placebo.